CLARITEV CORP CLASS A (CTEV) — insider trading
Health Care · NYSE
CLARITEV CORP CLASS A (CTEV) has 17 reported SEC Form 4 insider transactions in our data, including 5 open-market purchases and 2 open-market sales among the most recent 17 (latest 2026-08-14).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-08-14 | Misencik Tiffani | Officer (SVP, Chief Growth Officer) | Open-market sale | 8,850 | $40.07 | $354.6K | Form 4 |
| 2026-08-10 | Mintz William B. | Officer (SVP, Chief Strategy Officer) | Open-market sale | 8,431 | $34.24 | $288.7K | Form 4 |
| 2026-08-05 | Garis Douglas Michael | Officer (EVP&CFO) | Shares withheld for taxes / exercise cost | 11,711 | $26.13 | $306.0K | Form 4 |
| 2026-08-05 | Mintz William B. | Officer (SVP, Chief Strategy Officer) | Shares withheld for taxes / exercise cost | 3,622 | $26.13 | $94.6K | Form 4 |
| 2026-06-30 | Albinson Brock | Officer (SVP, Chief Accounting Officer) | Grant / award / vesting | 3,649 | — | $0 | Form 4 |
| 2026-06-09 | Carol Nutter | Officer (SVP, Chief People Officer) | Open-market purchase | 875 | $28.41 | $24.9K | Form 4 |
| 2026-05-19 | Prince John Michael | Director | Open-market purchase | 10,000 | $16.00 | $160.0K | Form 4 |
| 2026-05-18 | Dalton Travis | Director, Officer (Pres., CEO & Executive Chair) | Open-market purchase | 11,200 | $11.88 | $133.1K | Form 4 |
| 2026-05-18 | Dalton Travis | Director, Officer (Pres., CEO & Executive Chair) | Open-market purchase | 9,720 | $12.92 | $125.6K | Form 4 |
| 2026-05-18 | Kim Michael | Officer (EVP, Chief Digital Officer) | Open-market purchase | 3,000 | $16.65 | $50.0K | Form 4 |
| 2026-04-29 | Colaluca Anthony Jr | Director | Grant / award / vesting | 8,977 | — | $0 | Form 4 |
| 2026-04-29 | Prince John Michael | Director | Grant / award / vesting | 8,977 | — | $0 | Form 4 |
| 2026-04-29 | HARRIS C MARTIN | Director | Grant / award / vesting | 8,977 | — | $0 | Form 4 |
| 2026-04-29 | Kap Jason Lamar | Director | Grant / award / vesting | 8,977 | — | $0 | Form 4 |
| 2026-04-29 | Clarke Richard A | Director | Grant / award / vesting | 8,977 | — | $0 | Form 4 |
| 2026-04-29 | Klein Michael Stuart | Director | Grant / award / vesting | 8,977 | — | $0 | Form 4 |
| 2026-04-29 | Klapstein Julie D | Director | Grant / award / vesting | 8,977 | — | $0 | Form 4 |
Ask the chat about CTEV's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: CLARITEV CORP CLASS A (CTEV).
Last updated 2026-08-14 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.